Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis

Rosa Cortese^{1

2}, Marco Battaglini^{1

3}, Ferran Prados^{2

4

5}, Giordano Gentile^{1

3}, Ludovico Luchetti^{1

3}, Alessia Bianchi², Lukas Haider², Anu Jacob^{6

7}, Jacqueline Palace⁸, Silvia Messina⁸, Friedemann Paul⁹, Romain Marignier¹⁰, Françoise Durand-Dubief¹⁰, Carolina de Medeiros Rimkus¹¹, Samira Luisa Apostolos Pereira¹², Douglas Kazutoshi Sato¹³, Massimo Filippi^{14

15

16

17

18}, Maria Assunta Rocca^{14

15

18}, Laura Cacciaguerra^{14

15}, Àlex Rovira¹⁹, Jaume Sastre-Garriga²⁰, Georgina Arrambide²⁰, Yaou Liu²¹, Yunyun Duan²¹, Claudio Gasperini²², Carla Tortorella²², Serena Ruggieri^{23

24}, Maria Pia Amato^{25

26}, Monica Ulivelli¹, Sergiu Groppa²⁷, Matthias Grothe²⁸, Sara Llufriu²⁹, Maria Sepulveda²⁹, Carsten Lukas^{30

31}, Barbara Bellenberg³⁰, Ruth Schneider^{30

31}, Piotr Sowa³², Elisabeth G Celius³³, Anne-Katrin Pröbstel³⁴, Cristina Granziera^{34

35}, Özgür Yaldizli³⁴, Jannis Müller^{34

35}, Bruno Stankoff³⁶, Benedetta Bodini³⁶, Frederik Barkhof^{4

37}, Olga Ciccarelli^{2

38}, Nicola De Stefano¹; MAGNIMS Study Group

Collaborators, Affiliations

Collaborators

MAGNIMS Study Group:
F Barkhof, N de Stefano, J Sastre-Garriga, O Ciccarelli, C Enzinger, M Filippi, Claudio Gasperini, L Kappos, J Palace, H Vrenken, À Rovira, M A Rocca, T Yousry

Affiliations

¹ Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
² Queen Square MS Center, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
³ SIENA imaging SRL, Siena, Italy.
⁴ Center for Medical Imaging Computing, Medical Physics, and Biomedical Engineering, UCL, London, UK.
⁵ E-Health Center University Oberta de Catalunya, Barcelona, Spain.
⁶ NMO Clinical Service at the Walton Centre, Liverpool, UK.
⁷ Department of Neurology, Cleveland Clinic, Abu Dhabi, UAE.
⁸ Department of Clinical Neurology, John Radcliffe Hospital, Oxford, UK.
⁹ Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitaetsmedizin Berlin, Berlin, Germany.
¹⁰ Department of Neurology, Multiple Sclerosis, Myelin Disorders, and Neuro-inflammation, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Lyon, France.
¹¹ Department of Radiology and Oncology, Faculty of Medicine, University of São Paulo (FMUSP), São Paulo, Brazil.
¹² Department of Neurology, Faculty of Medicine, University of São Paulo (FMUSP), São Paulo, Brazil.
¹³ Pontifical Catholic University of Rio Grande do Sul (PUCRS), School of Medicine, Porto Alegre, Brazil.
¹⁴ Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹⁵ Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹⁶ Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹⁷ Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹⁸ Vita-Salute San Raffaele University, Milan, Italy.
¹⁹ Section of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
²⁰ Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
²¹ Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
²² Department of Neurosciences, S. Camillo-Forlanini Hospital, Rome, Italy.
²³ Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
²⁴ Neuroimmunology Unit, IRCSS Fondazione Santa Lucia, Rome, Italy.
²⁵ Department Neurofarba, University of Florence, Florence, Italy.
²⁶ IRCCS Don Carlo Gnocchi Foundation, Florence, Italy.
²⁷ Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
²⁸ Department of Neurology, University Medicine of Greifswald, Greifswald, Germany.
²⁹ Service of Neurology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Center of Neuroimmunology, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), and Universitat de Barcelona, Barcelona, Spain.
³⁰ Institute of Neuroradiology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
³¹ Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
³² Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
³³ Department of Neurology, Oslo University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway.
³⁴ Department of Neurology, Biomedicine and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital and University of Basel, Basel, Switzerland.
³⁵ Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.
³⁶ Sorbonne University, Paris Brain Institute, ICM, Pitié Salpêtrière Hospital, Paris, France.
³⁷ Radiology & Nuclear medicine, VU University Medical Center, Amsterdam, The Netherlands.
³⁸ National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Center, London, UK.

PMID: 38780377
DOI: 10.1002/ana.26951

Multicenter Study

Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis

Rosa Cortese et al. Ann Neurol. 2024 Aug.

. 2024 Aug;96(2):276-288.

doi: 10.1002/ana.26951. Epub 2024 May 23.

Authors

Collaborators

MAGNIMS Study Group:
F Barkhof, N de Stefano, J Sastre-Garriga, O Ciccarelli, C Enzinger, M Filippi, Claudio Gasperini, L Kappos, J Palace, H Vrenken, À Rovira, M A Rocca, T Yousry

Affiliations

¹ Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
² Queen Square MS Center, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
³ SIENA imaging SRL, Siena, Italy.
⁴ Center for Medical Imaging Computing, Medical Physics, and Biomedical Engineering, UCL, London, UK.
⁵ E-Health Center University Oberta de Catalunya, Barcelona, Spain.
⁶ NMO Clinical Service at the Walton Centre, Liverpool, UK.
⁷ Department of Neurology, Cleveland Clinic, Abu Dhabi, UAE.
⁸ Department of Clinical Neurology, John Radcliffe Hospital, Oxford, UK.
⁹ Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitaetsmedizin Berlin, Berlin, Germany.
¹⁰ Department of Neurology, Multiple Sclerosis, Myelin Disorders, and Neuro-inflammation, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Lyon, France.
¹¹ Department of Radiology and Oncology, Faculty of Medicine, University of São Paulo (FMUSP), São Paulo, Brazil.
¹² Department of Neurology, Faculty of Medicine, University of São Paulo (FMUSP), São Paulo, Brazil.
¹³ Pontifical Catholic University of Rio Grande do Sul (PUCRS), School of Medicine, Porto Alegre, Brazil.
¹⁴ Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹⁵ Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹⁶ Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹⁷ Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹⁸ Vita-Salute San Raffaele University, Milan, Italy.
¹⁹ Section of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
²⁰ Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
²¹ Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
²² Department of Neurosciences, S. Camillo-Forlanini Hospital, Rome, Italy.
²³ Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
²⁴ Neuroimmunology Unit, IRCSS Fondazione Santa Lucia, Rome, Italy.
²⁵ Department Neurofarba, University of Florence, Florence, Italy.
²⁶ IRCCS Don Carlo Gnocchi Foundation, Florence, Italy.
²⁷ Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
²⁸ Department of Neurology, University Medicine of Greifswald, Greifswald, Germany.
²⁹ Service of Neurology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Center of Neuroimmunology, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), and Universitat de Barcelona, Barcelona, Spain.
³⁰ Institute of Neuroradiology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
³¹ Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
³² Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
³³ Department of Neurology, Oslo University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway.
³⁴ Department of Neurology, Biomedicine and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital and University of Basel, Basel, Switzerland.
³⁵ Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.
³⁶ Sorbonne University, Paris Brain Institute, ICM, Pitié Salpêtrière Hospital, Paris, France.
³⁷ Radiology & Nuclear medicine, VU University Medical Center, Amsterdam, The Netherlands.
³⁸ National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Center, London, UK.

PMID: 38780377
DOI: 10.1002/ana.26951

Abstract

Objective: To evaluate: (1) the distribution of gray matter (GM) atrophy in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD), and relapsing-remitting multiple sclerosis (RRMS); and (2) the relationship between GM volumes and white matter lesions in various brain regions within each disease.

Methods: A retrospective, multicenter analysis of magnetic resonance imaging data included patients with MOGAD/AQP4+NMOSD/RRMS in non-acute disease stage. Voxel-wise analyses and general linear models were used to evaluate the relevance of regional GM atrophy. For significant results (p < 0.05), volumes of atrophic areas are reported.

Results: We studied 135 MOGAD patients, 135 AQP4+NMOSD, 175 RRMS, and 144 healthy controls (HC). Compared with HC, MOGAD showed lower GM volumes in the temporal lobes, deep GM, insula, and cingulate cortex (75.79 cm³); AQP4+NMOSD in the occipital cortex (32.83 cm³); and RRMS diffusely in the GM (260.61 cm³). MOGAD showed more pronounced temporal cortex atrophy than RRMS (6.71 cm³), whereas AQP4+NMOSD displayed greater occipital cortex atrophy than RRMS (19.82 cm³). RRMS demonstrated more pronounced deep GM atrophy in comparison with MOGAD (27.90 cm³) and AQP4+NMOSD (47.04 cm³). In MOGAD, higher periventricular and cortical/juxtacortical lesions were linked to reduced temporal cortex, deep GM, and insula volumes. In RRMS, the diffuse GM atrophy was associated with lesions in all locations. AQP4+NMOSD showed no lesion/GM volume correlation.

Interpretation: GM atrophy is more widespread in RRMS compared with the other two conditions. MOGAD primarily affects the temporal cortex, whereas AQP4+NMOSD mainly involves the occipital cortex. In MOGAD and RRMS, lesion-related tract degeneration is associated with atrophy, but this link is absent in AQP4+NMOSD. ANN NEUROL 2024;96:276-288.

PubMed Disclaimer

References

1. Lassmann H. The changing concepts in the neuropathology of acquired demyelinating central nervous system disorders. Curr Opin Neurol 2019;32:313–319. https://doi.org/10.1097/wco.0000000000000685.
1. Marignier R, Hacohen Y, Cobo‐Calvo A, et al. Myelin‐oligodendrocyte glycoprotein antibody‐associated disease. Lancet Neurol 2021;20:762–772. https://doi.org/10.1016/S1474-4422(21)00218-0.
1. Kuhlmann T, Marcello M, Timothy C, et al. “Personal View Multiple Sclerosis Progression: Time for a New Mechanism‐Driven Framework.” The Lancet Global Health 2022. https://doi.org/10.1016/S1474-4422(22)00289-7.
1. Ciccarelli O, Cohen JA, Reingold SC, et al. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. Lancet Neurol 2019;18:185–197. https://doi.org/10.1016/S1474-4422(18)30460-5.
1. Banwell B, Bennett JL, Marignier R, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody‐associated disease: international MOGAD panel proposed criteria. Lancet Neurol 2023;4422:1–15. https://doi.org/10.1016/s1474-4422(22)00431-8.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis

Collaborators

Affiliations

Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis

Authors

Collaborators

Affiliations

Abstract

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical